A Randomized Intervention, Multi-Center Study to Determine the Role of Fatty Acids in Serum in Preventing Retinopathy of Prematurity (MDM)
Phase of Trial: Phase II
Latest Information Update: 14 Nov 2018
At a glance
- Drugs Arachidonic acid (Primary) ; Docosahexaenoic acid (Primary)
- Indications Retinopathy of prematurity
- Focus Therapeutic Use
- 31 Oct 2018 Planned End Date changed from 31 Dec 2018 to 31 Dec 2019.
- 31 Oct 2018 Planned primary completion date changed from 1 May 2018 to 15 Nov 2019.
- 30 Jun 2017 New trial record